« Return to News | Clinical Intelligence

The CenterWatch Monthly, September 2013

Tuesday, September 3, 2013 08:00 AM

Sponsors look to collaborate on comparator drugs

New research suggests comparator drugs and co-therapies used in clinical studies comprise a larger proportion of clinical research budgets than previously thought—and contribute significantly to the rising cost of drug development.

Early adopters implement risk-based monitoring pilot programs

The drug development industry has begun to move forward in supporting risk-based monitoring models, yet sponsors and CROs remain uncertain about the best ways to implement this new approach and how regulatory agencies will respond. As a result, companies have launched experiments that, in the short term, will mean uncertainty and change across the clinical research enterprise.

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information. - See more at: http://www.centerwatch.com/news-online/article/5116/Preview#sthash.GkIkykxl.dpuf
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information. - See more at: http://www.centerwatch.com/news-online/article/5116/Preview#sthash.GkIkykxl.dpuf
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information. - See more at: http://www.centerwatch.com/news-online/article/5116/the-centerwatch-monthly-august-2013#sthash.bykvydjc.dpuf
Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.